Natixis Bio Techne Corp Transaction History

Natixis

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$62.12 - $84.15 $918,692 - $1.24 Million	14,789 New	14,789 $1.06 Million
Q4 2023 Feb 13, 2024	BUY	$52.83 - $78.22 $888,759 - $1.32 Million	16,823 New	16,823 $1.3 Million
Q4 2022 Feb 24, 2023	SELL	$80.67 - $352.29 $3.05 Million - $13.3 Million	-37,803 Reduced 97.05%	1,150 $95,000
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $2.84 Million - $12.4 Million	35,208 Added 940.13%	38,953 $3.23 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $203,711 - $282,523	721 Added 23.84%	3,745 $1.07 Million
Q2 2022 Aug 12, 2022	BUY	$322.67 - $449.65 $975,754 - $1.36 Million	3,024 New	3,024 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $495,835 - $570,740	-1,087 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $130,346 - $157,891	293 Added 36.9%	1,087 $527,000
Q2 2021 Aug 13, 2021	SELL	$387.35 - $450.26 $1.86 Million - $2.16 Million	-4,806 Reduced 85.82%	794 $358,000
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $4.66 Million - $6.08 Million	-14,805 Reduced 72.56%	5,600 $2.14 Million
Q2 2019 Aug 13, 2019	BUY	$188.72 - $215.43 $1.29 Million - $1.47 Million	6,845 Added 50.48%	20,405 $4.25 Million
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $1.85 Million - $2.72 Million	13,560 New	13,560 $2.67 Million

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.94B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.